EUVIMEDEUVIMED entdecken
Crossref

METTL3/IGF2BP2 stabilizes IQGAP3 via m6A modification to drive HCC metastasis through TGF-β/Smad signaling and EMT

Debiao Pan, Haiyuan Zhang, Junbin Zhou, Songqing He, Guandou Yuan

Pathology - Research and Practice · 2025

DOI: 10.1016/j.prp.2025.156228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Debiao Pan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China; Key Laboratory of Early Prevention an…. Hauptthemen laut MEDLINE: Methyltransferases, Liver Neoplasms, Epithelial-Mesenchymal Transition, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, Lishui University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) metastasis is a leading cause of mortality, yet its molecular drivers remain poorly defined. In this study, we identify methyltransferase-like 3 (METTL3), an N6-methyladenosine (m6A) RNA methyltransferase frequently upregulated in HCC, as a critical promoter of metastasis through m6A-mediated post-transcriptional upregulation of the oncogenic protein IQ motif-containing GTPase-activating protein 3 (IQGAP3). Using HCC cell lines in vitro and a nude mouse lung metastasis model in vivo, we demonstrate that METTL3-catalyzed m6A modification of IQGAP3 mRNA enhances IQGAP3 stability and expression, which in turn drives HCC cell migration, invasion, and lung colonization. METTL3 knockdown reduces m6A marks on IQGAP3 transcripts and decreases IQGAP3 levels and metastatic capacity, whereas ectopic IQGAP3 expression rescues the invasive phenotype. Mechanistically, RNA immunoprecipitation assays reveal that Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2), an m6A reader protein, binds m6A-modified IQGAP3 transcripts to prolong their half-life. Consequently, the METTL3-IQGAP3 axis activates TGF-β/Smad signaling and drives an epithelial-mesenchymal transition, thereby promoting a metastatic phenotype. Concordantly, METTL3 depletion or IGF2BP2 knockdown significantly suppresses these pathways and impedes metastasis in vitro and in vivo. Overall, our findings uncover a novel m6A-dependent mechanism driving HCC metastasis. This m6A-dependent METTL3-IGF2BP2-IQGAP3 axis represents a promising therapeutic target for metastatic HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethyltransferasesLiver NeoplasmsEpithelial-Mesenchymal TransitionCarcinoma, Hepatocellularras GTPase-Activating ProteinsRNA-Binding ProteinsHumansAnimalsSignal TransductionTransforming Growth Factor betaMiceMice, NudeGene Expression Regulation, NeoplasticSmad ProteinsCell MovementAdenosineNeoplasm MetastasisLung NeoplasmsCell Line, TumorGTPase-Activating Proteins

Stichwörter der Autor:innen

HCCIGF2BP2IQGAP3M6AMETTL3

Substanzen

MethyltransferasesMETTL3 protein, humanras GTPase-Activating ProteinsTransforming Growth Factor betaIQGAP3 protein, humanRNA-Binding ProteinsIGF2BP2 protein, humanN-methyladenosineSmad ProteinsAdenosine

Autor:innen und Institutionen

  • Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China; Key Laboratory of Early Prevention and Treatment for Regional High Frequency, Tumor (Guangxi Medical Univer…
  • Division of Hepatobiliary Surgery, The First Affiliated Hospital of Lishui University, Lishui people's Hospital, Lishui, China.

Förderung

  • Natural Science Foundation of Zhejiang Province
  • Lishui University

Zitieren

APA

Pan, D., Zhang, H., Zhou, J., He, S., & Yuan, G. (2025). METTL3/IGF2BP2 stabilizes IQGAP3 via m6A modification to drive HCC metastasis through TGF-β/Smad signaling and EMT. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.156228

Vancouver

Pan D, Zhang H, Zhou J, He S, Yuan G. METTL3/IGF2BP2 stabilizes IQGAP3 via m6A modification to drive HCC metastasis through TGF-β/Smad signaling and EMT. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.156228

BibTeX
@article{Pan2025,
  author = {Pan, Debiao and Zhang, Haiyuan and Zhou, Junbin and He, Songqing and Yuan, Guandou},
  title = {METTL3/IGF2BP2 stabilizes IQGAP3 via m6A modification to drive HCC metastasis through TGF-β/Smad signaling and EMT},
  journal = {Pathology - Research and Practice},
  year = {2025},
  doi = {10.1016/j.prp.2025.156228}
}
Kostenlos starten →